Let's look at some entyvio trial data.
www.entyviohcp.com said...
INFECTIONS
Infection rates with Entyvio were 0.85 per patient-year vs 0.7 for placebo
Infections consisted primarily of nasopharyngitis (common cold), upper respiratory tract infection, sinusitis, and urinary tract infection
/www.entyviohcp.com/safety-profile